Drug intelligence / Profile preview

Epiduo Forte

Development stage
Approved
Lead developer
Galderma
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

Epiduo Forte is a prescription topical medication that combines adapalene 0.3% and benzoyl peroxide 2.5% in a gel formulation. It is FDA-approved for the treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. Adapalene, a retinoid, works by normalizing skin cell turnover, preventing pores from being blocked, and reducing inflammation. Benzoyl peroxide has antibacterial effects against acne-causing bacteria and provides mild drying effects that help remove excess oils and dirt from the skin. The combination of these two active ingredients offers a comprehensive approach to acne treatment, with studies showing significant reduction in both inflammatory and non-inflammatory acne lesions over a 12-week period.

Brand names
Epiduo Forte
Other names
adapalene 0.3%-benzoyl peroxide 2.5% gelA/BPO 0.3/2.5 gel
02

Targets

RARB (Retinoic acid receptor beta)RARA (Retinoic acid receptor alpha)RARG (Retinoic acid receptor gamma)

Beyond the preview

Go deeper on Epiduo Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epiduo Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call